BAC vs PHG Stock Comparison
PHG currently leads BAC in this stock comparison, with AIQ scores of 72 vs 56. The clearest difference is momentum, while BAC has the stronger risk resilience profile.
What is the main difference between BAC and PHG?
PHG leads the current stock comparison as Koninklijke Philips N.V., with the clearest separation coming from momentum and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Bank of America Corporation vs Koninklijke Philips N.V.
PHG leads
PHG leads by 16 AIQ points, primarily on Momentum and Value, and the lead has widened from 1 points over 30 sessions.
Competitive: 3 of 5 evidence groups support PHG, its lead is widening, and its current signal state is conflicted.
Bank of America Corporation
Koninklijke Philips N.V.
The Algovestiq AIQ Score currently favors PHG over BAC, 72 versus 56 as of Nov 18, 2026. PHG's advantage is driven primarily by stronger momentum and value, while BAC holds the stronger risk resilience profile. PHG also shows the stronger technical structure relative to its 50-day moving average. 3 of 5 covered evidence groups favor PHG today, and the comparison is rated Competitive on stability: the leader is throwing conflicting signals. PHG lead: Strengthening — the AIQ differential moved from 1 to 16 points over 30 sessions.
Compare Bank of America Corporation and Koninklijke Philips N.V. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare BAC and PHG against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Momentum34 vs 72PHG +38
- Value65 vs 80PHG +15
- Risk Resilience83 vs 73BAC +10
- Quality64 vs 67Even
3 of 5 evidence groups favor PHG. PHG’s edge is concentrated in momentum and value; BAC keeps a meaningful risk resilience edge.
What changed since the last close
Latest scored session 2026-11-18, compared against the prior scored session 2026-11-17.
Largest factor move: Value -3
New signals
- OBV Bullish Divergence — bullish, volume, medium horizon (-0.4%)
Largest factor move: Value +1, not enough on its own to move the overall score.
New signals
- RSI Overbought — bearish, momentum, short horizon
PHG's lead widened by 1 AIQ point in the latest session.
Deeper signal detail for each name lives on its own signals page — BAC and PHG both carry a full feed there.
The central trade-off
PHG (Koninklijke Philips N.V.): the stronger current systematic profile, led by momentum and value.
BAC (Bank of America Corporation): the counter-case, on risk resilience, fundamentals.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
PHGPHG on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
BACBAC on combined revenue and EPS growth.
Value
PHGPHG on the peer-relative Value factor, by 15 points.
Momentum
PHGPHG on the Momentum factor, by 38 points.
Lower downside
BACBAC on Risk Resilience, by 10 points.
Analyst upside
EvenAnalyst targets are level or not covered for both names.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | BAC | PHG | Note |
|---|---|---|---|
| Implied upside to target | +29.4% | — | Level |
| Target dispersion | +25.3% | — | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 25 | 5 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
3 of 5 covered evidence groups favor PHG. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | PHG | 56 vs 72 |
| Fundamentals | BAC | EPS growth -23.8% vs -93.1%; TTM ROE 2.3% vs 0.2%; gross margin 60.4% vs 46.4%; operating margin 22.4% vs 10.9% |
| Valuation | PHG | Value 65 vs 80 |
| Technicals | PHG | Price vs 50-day -9.5% vs 14%; vs 200-day -7% vs 11.4% |
| Risk Resilience | BAC | Risk Resilience 83 vs 73 |
| Analyst expectations | Not covered | Not covered |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of BAC and PHG and are excluded from the count.
AIQ Decision Stability
The two are close enough that your objective, not the score, should decide.
- The AIQ gap is wide at 16 points. (supports the conclusion holding)
- The leader's advantage has been widening. (supports the conclusion holding)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on PHG.
How the comparison changed
120 daily snapshots · Jun 1 – Nov 18PHG lead: Strengthening — the AIQ differential moved from 1 to 16 points over 30 sessions.
- Today
- PHG +16
- 56 vs 72
- 7 sessions ago
- PHG +15
- 58 vs 73
- 30 sessions ago
- PHG +1
- 62 vs 63
- 90 sessions ago
- BAC +10
- 70 vs 60
The lead has not changed hands in this window.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
2 bullish / 2 bearish / 1 neutral, conflicted
Only BAC
- Bollinger Band Squeeze — neutral, volatility, short horizon (4.5%)
- Downtrend Structure Active — bearish, trend, long horizon
- MACD Histogram Expanding Bullish — bullish, momentum, short horizon
- OBV Bullish Divergence — bullish, volume, medium horizon (-0.4%)
3 bullish / 2 bearish / 1 neutral, conflicted
Only PHG
- ADX Trend Strengthening — neutral, trend, medium horizon
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
- Keltner Channel Breakout — bullish, volatility, short horizon
- RSI Overbought — bearish, momentum, short horizon
- TRIX Bullish Signal — bullish, momentum, short horizon
Both carry 1 more signal that do not separate them: Death Cross Active.
PHG leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price and the AIQ Score both moved down over the latest session (price -1.07%, AIQ -1 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.27%, AIQ 0 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1BAC closes the Momentum gap — currently 38 points behind, the largest single contributor to PHG's edge.
- 2BAC's Death Cross Active resolves — a bearish trend rule currently active against it.
- 3PHG's conflicting signal state resolves bearish — it currently carries 3 bullish and 2 bearish rules at once.
- 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
BAC leads on balance| Metric | BAC | PHG |
|---|---|---|
| Revenue growth (YoY) | -3.3% | 0.2% |
| EPS growth (YoY) | -23.8% | -93.1% |
| Gross margin | 60.4% | 46.4% |
| Operating margin | 22.4% | 10.9% |
| Return on equity (TTM) | 2.3% | 0.2% |
| Debt to equity | 1.28 | 0.7 |
Performance
PHG leads 5 of 6 windows| Metric | BAC | PHG |
|---|---|---|
| 1 week (5 sessions) | 3.2% | 0% |
| 1 month (20 sessions) | -0.4% | 17.9% |
| 3 months (63 sessions) | -20.1% | 13.1% |
| 6 months (126 sessions) | 2.5% | 20.3% |
| Year to date | -7.2% | 12% |
| 1 year (252 sessions) | -5.7% | 3.3% |
Technicals
PHG has the stronger structure| Metric | BAC | PHG |
|---|---|---|
| RSI (14) | 45.9 | 70.9 |
| ADX (14) | 27.2 | 43.2 |
| Price vs 50-day | -9.5% | 14% |
| Price vs 200-day | -7% | 11.4% |
| Volatility (1M, annualized) | 24.8% | 38.9% |
Risk
BAC is the more resilient| Metric | BAC | PHG |
|---|---|---|
| Beta | 0.79 | 0.85 |
| Sharpe ratio | -0.22 | 0.18 |
| Sortino ratio | -0.29 | 0.27 |
| Max drawdown | -23.7% | -27.7% |
| Current drawdown | -21.3% | -7.8% |
| Annualized volatility | 22.4% | 29.7% |
| Value at risk (95%) | -2.6% | -2.5% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, BAC or PHG?
On the Algovestiq AIQ Score, PHG is the stronger of the two as of Nov 18, 2026, scoring 72 against BAC's 56. The edge comes from momentum and value. BAC is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is BAC or PHG the better buy right now?
PHG carries the stronger systematic profile as of Nov 18, 2026, and the comparison is rated Competitive — 3 of 5 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.
Why does the AIQ Score favor PHG over BAC?
The composite weights Quality, Value, Momentum and Risk Resilience. PHG leads Momentum by 38 points; PHG leads Value by 15 points; BAC leads Risk Resilience by 10 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, BAC or PHG?
Analyst price targets imply +29.4% upside for BAC and not covered for PHG. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, BAC or PHG?
PHG is the better-valued of the two on the peer-relative Value factor. PHG on the peer-relative Value factor, by 15 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, BAC or PHG?
BAC on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, BAC or PHG?
PHG on the Momentum factor, by 38 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, BAC or PHG?
BAC is the more resilient of the two, so the other name carries the higher downside risk. BAC on Risk Resilience, by 10 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is BAC more profitable than PHG?
BAC leads on the comparable margin measures — gross margin 60.4% vs 46.4%; operating margin 22.4% vs 10.9%; ttm roe 2.3% vs 0.2%.
Is PHG's lead over BAC getting stronger or weaker?
PHG lead: Strengthening — the AIQ differential moved from 1 to 16 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-06-01 and 2026-11-18. The lead has not changed hands in that window.
What would change the BAC vs PHG verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: BAC closes the Momentum gap — currently 38 points behind, the largest single contributor to PHG's edge; BAC's Death Cross Active resolves — a bearish trend rule currently active against it; PHG's conflicting signal state resolves bearish — it currently carries 3 bullish and 2 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
What do the current signals say about BAC and PHG?
BAC: 2 bullish / 2 bearish / 1 neutral, conflicted. PHG: 3 bullish / 2 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on BAC is Death Cross Active (bearish, long horizon). On PHG it is Death Cross Active (bearish, long horizon).
Compare BAC and PHG with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.